Compugen Ltd. (NASDAQ: CGEN) today announced that it will present aspects of its immune checkpoint related research at two scientific conferences this month.
On February 9, Arthur Machlenkin, PhD, Head of Immunology Group at Compugen, will deliver an oral presentation at the Keystone Symposia: Tumor Immunology - Multidisciplinary Science Driving Combination Therapy being held from February 8-13, in Banff, Canada.
Help employers find you! Check out all the jobs and post your resume.
On February 9, Arthur Machlenkin, PhD, Head of Immunology Group at Compugen, will deliver an oral presentation at the Keystone Symposia: Tumor Immunology - Multidisciplinary Science Driving Combination Therapy being held from February 8-13, in Banff, Canada.
Help employers find you! Check out all the jobs and post your resume.
